GlassScriptPhysician profile
Tyler R Wayment
NPI 1669423539
$8,391.62
in general payments reported to CMS, 2019-2025
18 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,395 · 2020: $43.57 · 2021: $60.58 · 2022: $111 · 2023: $91.97 · 2024: $4,547 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,163 · Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,162.81 |
| Food and Beverage | $618.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $4,162.81 | 2024 | |
| Aptis Medical, LLC | $3,276.06 | 2019 | |
| Endo Pharmaceuticals INC. | $327.97 | 2019-2024 | Xiaflex |
| Arthrex, INC. | $139.84 | 2024 | Biologics Consumables Wound Care Patch, Arthrex |
| Anika Therapeutics, INC. | $84.43 | 2024 | Wristmotion |
| Djo, LLC | $58.00 | 2019 | |
| Sawtooth Surgical Solutions INC | $53.97 | 2025 | |
| Davol INC. | $45.71 | 2025 | Surgiphor |
| Endo USA, INC. | $39.60 | 2024-2025 | Xiaflex |
| Zimmer Biomet Holdings, INC. | $38.25 | 2024 | Tapestry |
| Mentor Worldwide LLC | $37.59 | 2024 | Mentor Memorygel Resterilizable Gel Sizer, Stratafix |
| Integra Lifesciences Corporation | $36.10 | 2019-2022 | |
| Acumed LLC | $34.64 | 2021-2022 | |
| Medtronic, INC. | $16.25 | 2023 | Plasmablade(Tm) |
| Allergan, INC. | $14.44 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $13.95 | 2025 | Irrisept |
| Skeletal Dynamics INC | $12.01 | 2025 | Ijs, Geminus, Implate |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$176,790.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Wayment listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.